• 1
    Swamynathan SK, Nambiar A, Guntaka RV. Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J 1998; 12: 51522.
  • 2
    Ashizuka M, Fukuda T, Nakamura T et al . Novel translational control through an iron–responsive element by interaction of multifunctional protein YB-1 and IRP2. Mol Cell Biol 2002; 22: 637583.
  • 3
    Stickeler E, Fraser SD, Honig A, Chen AL, Berget SM, Cooper TA. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J 2001; 20: 382130.
  • 4
    Hayakawa H, Uchiumi T, Fukuda T et al . Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry 2002; 41: 1273944.
  • 5
    Koike K, Uchiumi T, Ohga T et al . Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett 1997; 417: 3904.
  • 6
    Bargou RC, Jurchott K, Wagener C et al . Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 1997; 3: 44750.
  • 7
    Janz M, Harbeck N, Dettmar P et al . Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer 2002; 97: 27882.
  • 8
    Oda Y, Ohishi Y, Saito T et al . Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma. J Pathol 2003; 199: 2518.
  • 9
    Rubinstein DB, Stortchevoi A, Boosalis M, Ashfaq R, Guillaume T. Overexpression of DNA-binding protein B gene product in breast cancer as detected by in vitro-generated combinatorial human immunoglobulin libraries. Cancer Res 2002; 62: 498591.
  • 10
    Yahata H, Kobayashi H, Kamura T et al . Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer. J Cancer Res Clin Oncol 2002; 128: 6216.
  • 11
    Ohga T, Uchiumi T, Makino Y et al . Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem 1998; 273: 59976000.
  • 12
    Gaudreault I, Guay D, Lebel M. YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. Nucl Acids Res 2004; 32: 31627.
  • 13
    Marenstein DR, Ocampo MT, Chan MK et al . Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. J Biol Chem 2001; 276: 212429.
  • 14
    Marenstein DR, Chan MK, Altamirano A et al . Substrate specificity of human endonuclease III (hNTH1). Effect of human APE1 on hNTH1 activity. J Biol Chem 2003; 278: 900512.
  • 15
    Ohga T, Koike K, Ono M et al . Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res 1996; 56: 42248.
  • 16
    Schmutte C, Sadoff MM, Shim KS, Acharya S, Fishel R. Role of the human Y-box binding protein YB-1 in cellular sensitivity to DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. J Biol Chem 2001; 276: 330118.
  • 17
    Moggs JG, Yarema KJ, Essigmann JM, Wood RD. Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d (GpTpG) -cisplatin adduct. J Biol Chem 1996; 271: 717786.
  • 18
    Izumi H, Imamura T, Nagatani G et al . Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3′[RIGHTWARDS ARROW]5′ exonuclease activity. Nucl Acids Res 2001; 29: 12007.
  • 19
    Liu X, Choudhury S, Roy R. In vitro and in vivo dimerization of human endonuclease III stimulates its activity. J Biol Chem 2003; 278: 500619.
  • 20
    Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicol 2007 [Epub ahead of print].
  • 21
    Sasada T, Iwata S, Sato N et al . Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest 1996; 97: 226876.
  • 22
    Jurchott K, Bergmann S, Stein U et al . YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 2003; 278: 2798896.
  • 23
    Bader AG, Vogt PK. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation. Mol Cell Biol 2005; 25: 2095106.
  • 24
    Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res 2001; 478: 2343.
  • 25
    Shibahara K, Uchiumi T, Fukuda T et al . Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C. Cancer Sci 2004; 95: 34853.
  • 26
    Sutherland BW, Kucab J, Wu J et al . Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005; 24: 428192.
  • 27
    Winograd-Katz SE, Levitzki A. Cisplatin induces PKB/Akt activation and p38 (MAPK) phosphorylation of the EGF receptor. Oncogene 2006; 25: 738190.
  • 28
    Wan YS, Wang ZQ, Shao Y, Voorhees JJ, Fisher GJ. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol 2001; 18: 4616.
  • 29
    Madhusudan S, Smart F, Shrimpton P et al . Isolation of a small molecule inhibitor of DNA base excision repair. Nucl Acids Res 2005; 33: 471124.